Literature DB >> 975552

More sensitive high-pressure liquid-chromatographic determiantion of theophylline in serum.

R F Adams, F L Vandemark, G J Schmidt.   

Abstract

We present procedures for determining theophylline in 50 mul of serum. The drug is extracted into a small volume of solvent that contains an internal standard, 8-chlorotheophylline. The extract is Analyzed by isocratic reversedphase chromatography, with measurement of eluted theophylline at 273 nm. Day-to-day reproducibility within 5% is attainable for the concentration range 5--20 mg/liter. Other xanthines and related metabolites do not interfere. Sensitivity is 1 mg/liter. The correlation coefficient, when results by a spectrophotometric procedure were compared, was 0.989. Amobarbital, secobarbital, phenobarbital, and diphenylhydantoin do not interfere. Total analysis time for a single sample is 15 min.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975552

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Rapid and sensitive gas-chromatographic determination of caffeine in blood plasma, saliva, and xanthine beverages.

Authors:  H W Teeuwen; E L Elbers; J M van Rossum
Journal:  Mol Biol Rep       Date:  1991-02       Impact factor: 2.316

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

Authors:  T Ishizaki; M Watanabe; N Morishita
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 5.  Drug interferences with plasma assays in therapeutic drug monitoring.

Authors:  S Yosselson-Superstine
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

6.  Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.

Authors:  Y Horai; T Ishizaki; T Sasaki; K Chiba; T Suganuma; H Echizen; A Ohnishi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.

Authors:  P Mojaverian; M L Rocci; C L Saccar; P H Vlasses; R K Ferguson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

8.  Food does not effect in bioavailability of theophylline from Theolin Retard.

Authors:  A P Sips; P M Edelbroek; S Kulstad; F A de Wolff; J H Dijkman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Components of variability in serum theophylline concentrations during maintenance therapy with a sustained release formulation.

Authors:  H Halkin; A Mazar; S Almog; Y Schnaps
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.

Authors:  Y Horai; T Ishizaki; T Sasaki; M Watanabe; J Kabe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.